abstract |
The present invention relates to a compound of structure (I), behaving as a noncompetitive specific inhibitor of glycoprotein P (P-gp for "Pleiotropic glycoprotein"), useful as a medicament, in particular for the improvement of efficacy chemotherapeutic treatments. The present invention therefore has applications in particular in the medical field, particularly in the context of chemotherapeutic treatments for cancers or infections. |